Cellebrite (CLBT) Director Brandon Van Buren Receives RSUs

What Happened

• Brandon Van Buren, a director of Cellebrite DI Ltd. (CLBT), was granted 15,190 restricted share units (RSUs) on September 17, 2026. The units were granted at a $0.00 acquisition price (standard for awards); no cash changed hands.

Key Details

• Transaction date: 2026-09-17 (filing date: 2026-09-17).
• Security and amount: 15,190 RSUs granted; reported acquisition price $0.00.
• Vesting/settlement: Footnote indicates these RSUs vest on September 17, 2027; each RSU represents a contingent right to receive one ordinary share upon settlement.
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1 plan, tax withholding, or cashless exercise noted in the filing.
• Filing timeliness: Report filed on the same date as the transaction (no lateness indicated).

Context

• RSUs are a form of equity compensation that convert into company shares (or cash equivalent) only if vesting conditions are met; they are not an open-market purchase and do not necessarily reflect immediate insider sentiment. This grant increases potential future dilution if and when the RSUs are settled.